Drawing for GATOR

USPTO serial 88215127

GATOR

Reviewed by CopyMark Law Group

Reg. 5998057Status 705Registered
Filing date
Status date
Registration date
Feb 25, 2020
Examiner
GALBO, AMANDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with GATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Viola T. Kung

Viola T. Kung PERKINS COIE LLP3150 PORTER DRIVEPALO ALTO, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents for reacting with biomolecules for scientific and research use; Reagents for scientific or and research use; Reagents for diagnostic use being diagnostic reagents and preparations, except for medical or veterinary use; Biochemical reagents used for non-medical purposes for detecting and analyzing molecules in protein or nucleotide arrays; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens or antibody in liquid, cell and tissue analysis for in vitro diagnostic useACTIVEMay 29, 2018
005[Medical reagents being reagents for medical use; Medical diagnostic reagents; Diagnostic preparations for medical purposes; Diagnostic reagents for detecting biomarker for medical purposes; Medical diagnostic reagents for testing of body fluids; Medical diagnostic reagents for the testing of body fluids; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids]SECTION 8 - CANCELLEDMay 29, 2018
009Optical instruments for measuring reaction by changing light reflection, namely, interferometer; Imaging apparatus and instruments for use in the study of proteins and nucleic acids for research purposes; Laboratory instrument in the nature of interferometer for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development; Probes for scientific purposes; Computer software for scientific and medical analysis, namely, for antibody titer determination and isotypingACTIVEMay 29, 2018
010[Medical instruments, namely, diagnostic instruments for the analysis of body fluids through the measuring of light interference; Medical diagnostic instruments for the analysis of body fluids through the measuring of light interference; Medical diagnostic tool to investigate scientific questions and conduct tests being interferometers for medical use; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays for medical purposes; Diagnostic kits consisting primarily of antibodies and reagents for use in disease testing]SECTION 8 - CANCELLEDMay 29, 2018
042Scientific laboratory services, namely, measurement and analysis of biomolecules by interaction between biomolecules; Basic scientific and clinical research in the field of biomolecules; Biological research; Research and development services in the field of antibodiesACTIVEMay 29, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 30, 2026C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 25, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Feb 25, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 25, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 21, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 31, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 31, 2019EX1GSOU EXTENSION 1 GRANTED—
Dec 31, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 19, 2019IUAFUSE AMENDMENT FILED—
Dec 19, 2019EXT1SOU EXTENSION 1 FILED—
Dec 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 2, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 29, 2019ALIEASSIGNED TO LIE—
Mar 8, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 8, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 8, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 8, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 8, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2019DOCKASSIGNED TO EXAMINER—
Dec 20, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance